Stock DNA
Capital Markets
USD 208 Million (Micro Cap)
NA (Loss Making)
NA
2.84%
-999,999.00
25.57%
0.95
Total Returns (Price + Dividend) 
SuRo Capital Corp. for the last several years.
Risk Adjusted Returns v/s 
News

SuRo Capital Corp. Hits New 52-Week High of $10.34, Up 149.69%
SuRo Capital Corp. achieved a new 52-week high, reflecting a substantial increase in performance over the past year. The company reported significant growth in operating profit and net sales, alongside a strong return on equity. Despite losses, it maintains a dividend yield and solid institutional backing.
Read More
SuRo Capital Corp. Hits New 52-Week High of $10.27
SuRo Capital Corp. has achieved a new 52-week high, reflecting a significant stock appreciation over the past year. The company reported impressive financial metrics, including a substantial increase in operating profit and net sales. With effective management and strong institutional holdings, SuRo Capital demonstrates resilience in the capital markets sector.
Read More
SuRo Capital Corp. Hits New 52-Week High of $10.05
SuRo Capital Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company reported impressive financial metrics, including substantial growth in operating profit and net sales, alongside a strong return on equity and favorable market valuation indicators.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 7 Schemes (8.48%)
Held by 11 Foreign Institutions (1.23%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 4,180.00% vs -95.15% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 7,887.50% vs 0.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 90.74% vs -125.00% in Dec 2023
YoY Growth in year ended Dec 2024 is -847.06% vs 103.86% in Dec 2023






